We are live on ! Find out more
KRMD icon

KORU Medical Systems

61 hedge funds and large institutions have $63.3M invested in KORU Medical Systems in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more call options, than puts

Call options by funds: $21K | Put options by funds: $5K

188% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 8

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

15% more funds holding

Funds holding: 5361 (+8)

2.17% more ownership

Funds ownership: 38.06%40.23% (+2.2%)

13% less capital invested

Capital invested by funds: $73.2M → $63.3M (-$9.84M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
61
Holders Change
+8
Holders Change %
+15.09%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
16
Increased
23
Reduced
8
Closed
8
Calls
$21K
Puts
$5K
Net Calls
+$16K
Net Calls Change
+$7K
Name Holding Trade Value Shares
Change
Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
26
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$171K +$151K +38,460 +343%
N
27
Nuveen
North Carolina
$170K +$193K +49,262 New
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$154K
Osaic Holdings
29
Osaic Holdings
Arizona
$148K +$19.2K +4,895 +13%
HighTower Advisors
30
HighTower Advisors
Illinois
$132K
Morgan Stanley
31
Morgan Stanley
New York
$126K -$52.6K -13,399 -27%
Jane Street
32
Jane Street
New York
$124K -$47.5K -12,107 -25%
EAM
33
Eagle Asset Management
Florida
$110K
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$97.6K +$111K +28,281 New
JP Morgan Chase
35
JP Morgan Chase
New York
$96.1K +$93.9K +23,925 +608%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$86.3K +$98.1K +25,000 New
BA
37
Bard Associates
Illinois
$75.2K -$1.12K -286 -1%
Mirae Asset Global Investments
38
Mirae Asset Global Investments
South Korea
$73K +$83K +21,156 New
UBS Group
39
UBS Group
Switzerland
$70.8K +$77.2K +19,670 +2,336%
MIM
40
MetLife Investment Management
New Jersey
$64.5K +$73.4K +18,708 New
Invesco
41
Invesco
Georgia
$61.6K +$70.1K +17,848 New
AIG
42
American International Group
New York
$58K +$66K +16,825 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$57K +$41.5K +10,570 +175%
SFA
44
Souders Financial Advisors
Ohio
$52K
CCM
45
Carlson Capital Management
Minnesota
$51.8K
Creative Planning
46
Creative Planning
Kansas
$50.6K
Wells Fargo
47
Wells Fargo
California
$50.4K +$56.3K +14,350 +5,335%
Prudential Financial
48
Prudential Financial
New Jersey
$49.1K +$7.24K +1,845 +15%
OQS
49
Occudo Quantitative Strategies
Florida
$43.7K +$49.7K +12,664 New
TRCT
50
Tower Research Capital (TRC)
New York
$40.6K +$41.1K +10,476 +804%

KRMD Hedge Fund Activity: Q2 2023 in Review

61 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in KORU Medical Systems (KRMD) for Q2 2023, worth a combined $63.3M — down 13% from $73.2M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new KRMD positions and 8 closed out — a net gain of 8 holders — while 23 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $4.16M. The largest seller was First Light Asset Management, cutting an estimated $3.5M.

  • 61 institutional investors held KORU Medical Systems (KRMD) as of Q2 2023, up from 53 in Q1 2023.
  • Funds reported $63.3M of KORU Medical Systems stock for Q2 2023, down 13% quarter-over-quarter.
  • 16 funds opened new KORU Medical Systems positions in Q2 2023 and 8 closed out, a net change of +8 holders.
  • The largest KORU Medical Systems buyer in Q2 2023 was BlackRock, an estimated $4.16M added.
  • The largest KORU Medical Systems seller in Q2 2023 was First Light Asset Management, an estimated $3.5M sold.

Based on aggregated 13F filings for Q2 2023.